Sat.Dec 30, 2023

article thumbnail

Biopharma dealmaking: predictions for 2024

European Pharmaceutical Review

The past 12 months has seen significant growth in global mergers and acquisitions (M&A) within the biopharma sector. This activity is expected to continue in 2024, with increasing need for biopharma to access innovation through collaboration and dealmaking to offset looming patent challenges. “In 2023, total life sciences deal value increased by 34 percent to $191 billion.

article thumbnail

The race to develop innovative products and supply chain solutions

pharmaphorum

In the final instalment of the five-part, festive series of the pharmaphorum podcast, host Nicole Raleigh speaks with Cencora’s SVP of international commercialisation, Sandra Anderson, and SVP and international managing director of Alloga Europe and ICS, Chris Williams. The topic of discussion centres around considerations and challenges when it comes to launching a biopharmaceutical product in Europe.

62
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Top 5 Pharmacy Times Specialty Pharmacy Articles of 2023

Pharmacy Times

From newsworthy moments to groundbreaking research, these were the most-read specialty pharmacy-related articles on Pharmacy Times in 2023.

article thumbnail

Which pharmaceutical companies have the most drug patents in Singapore?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most patents in Singapore. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is… The post Which pharmaceutical companies have the most drug patents in Singapore? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.